Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pro-Pro-Thr-Val-Pro-Thr-Arg

EU orphan designation number: EU/3/14/1375   
Active ingredient: Pro-Pro-Thr-Val-Pro-Thr-Arg
Indication: Treatment of xeroderma pigmentosum
Sponsor: ProGeLife S.A.S.
8 rue Sainte Barbe,13001 Marseille France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/155/14 (2014)8871 of 19/11/2014
20/06/2016 Transfer of orphan designation EMA/OD/155/14/T/01 (2016)3841 of 16/06/2016